Pre-Therapeutic Dosimetry Employing Scandium-44 for Radiolabeling PSMA-617
Author:
Publisher
IntechOpen
Link
http://www.intechopen.com/download/pdf/62261
Reference72 articles.
1. UNPB. World Health Organization. International Agency for Research on Cancer. May 15, 2018. http://gco.iarc.fr/today/fact-sheets-cancers?cancer=19&type=0&sex=1
2. Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, Schlenkhoff CD, et al. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer. Oncotarget. 2016;7:12477-12488. DOI: 10.18632/oncotarget.7245
3. Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, Essler M, et al. German Multicenter study investigating 177Lu-PSMA-617 Radioligand therapy in advanced prostate Cancer patients. Journal of Nuclear Medicine. 2017;58:85-90. DOI: 10.2967/jnumed.116.183194
4. Ghosh A, Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. Journal of Cellular Biochemistry. 2004;91:528-539. DOI: 10.1002/jcb.10661
5. Ahmadzadehfar H. Targeted therapy for metastatic prostate cancer with radionuclides. In: Mohan R, editor. Prostate Cancer - Leading-Edge Diagnostic Procedures and Treatments. Croatia: InTech; 2016. DOI: 10.5772/64016
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis;International Journal of Molecular Sciences;2023-04-17
2. Feasibility study of imaging with tissue-scattered triple-γ coincidence events in Compton-PET;Journal of Instrumentation;2022-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3